Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Diagnosis and Management of Primary Biliary Cholangitis.

Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM.

Am J Gastroenterol. 2019 Jan;114(1):48-63. doi: 10.1038/s41395-018-0390-3.

PMID:
30429590
2.

Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.

Bowlus CL, Kenney JT, Rice G, Navarro R.

J Manag Care Spec Pharm. 2016 Oct;22(10-a-s Suppl):S3-S15. Review.

3.

Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.

Pate J, Gutierrez JA, Frenette CT, Goel A, Kumar S, Manch RA, Mena EA, Pockros PJ, Satapathy SK, Yimam KK, Gish RG.

BMJ Open Gastroenterol. 2019 Feb 1;6(1):e000256. doi: 10.1136/bmjgast-2018-000256. eCollection 2019.

4.

[An interpretation of 2017 EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis].

Han Y, Chen Y.

Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):814-818. doi: 10.3760/cma.j.issn.1007-3418.2017.11.004. Chinese.

PMID:
29325274
5.

Symptoms of PBC - Pathophysiology and management.

Khanna A, Leighton J, Lee Wong L, Jones DE.

Best Pract Res Clin Gastroenterol. 2018 Jun - Aug;34-35:41-47. doi: 10.1016/j.bpg.2018.06.007. Epub 2018 Jun 14. Review.

PMID:
30343709
6.

Current and promising therapy for primary biliary cholangitis.

Gossard AA, Lindor KD.

Expert Opin Pharmacother. 2019 Jun;20(9):1161-1167. doi: 10.1080/14656566.2019.1601701. Epub 2019 Apr 22.

PMID:
30931642
7.

Obeticholic acid for the treatment of primary biliary cholangitis.

Ali AH, Lindor KD.

Expert Opin Pharmacother. 2016 Sep;17(13):1809-15. doi: 10.1080/14656566.2016.1218471. Epub 2016 Aug 9. Review.

PMID:
27468093
8.

Investigational drugs in phase II clinical trials for primary biliary cholangitis.

Silveira MG, Lindor KD.

Expert Opin Investig Drugs. 2017 Oct;26(10):1115-1121. doi: 10.1080/13543784.2017.1371135. Epub 2017 Aug 31. Review.

PMID:
28836457
9.

Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

Tabibian JH, Lindor KD.

Expert Opin Drug Saf. 2015;14(9):1435-44. doi: 10.1517/14740338.2015.1073260. Epub 2015 Jul 28. Review.

PMID:
26212223
10.

Emerging drugs for the treatment of Primary Biliary Cholangitis.

Ali AH, Tabibian JH, Carey EJ, Lindor KD.

Expert Opin Emerg Drugs. 2016;21(1):39-56. Review.

PMID:
26901615
11.

Primary Biliary Cholangitis Associated with Skin Disorders: A Case Report and Review of the Literature.

Terziroli Beretta-Piccoli B, Guillod C, Marsteller I, Blum R, Mazzucchelli L, Mondino C, Invernizzi P, Gershwin ME, Mainetti C.

Arch Immunol Ther Exp (Warsz). 2017 Aug;65(4):299-309. doi: 10.1007/s00005-016-0448-0. Epub 2017 Jan 25. Review.

PMID:
28124078
12.

Chronic cholestatic diseases.

Poupon R, Chazouillères O, Poupon RE.

J Hepatol. 2000;32(1 Suppl):129-40. Review.

PMID:
10728800
13.

Osteoporosis in primary biliary cholangitis.

Danford CJ, Trivedi HD, Papamichael K, Tapper EB, Bonder A.

World J Gastroenterol. 2018 Aug 21;24(31):3513-3520. doi: 10.3748/wjg.v24.i31.3513. Review.

14.

Management of symptom complexes in primary biliary cholangitis.

Kuo A, Kuo A, Bowlus CL.

Curr Opin Gastroenterol. 2016 May;32(3):204-9. doi: 10.1097/MOG.0000000000000254. Review.

PMID:
26825590
15.

Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective.

Marchioni Beery RM, Vaziri H, Forouhar F.

J Clin Transl Hepatol. 2014 Dec;2(4):266-84. doi: 10.14218/JCTH.2014.00024. Epub 2014 Dec 15. Review. Erratum in: J Clin Transl Hepatol. 2015 Jun 28;3(2):162.

16.

Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.

Zein CO, Lindor KD.

Curr Gastroenterol Rep. 2010 Feb;12(1):13-22. doi: 10.1007/s11894-009-0079-2. Review.

PMID:
20425480
17.

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver.

J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Epub 2017 Apr 18.

PMID:
28427765
18.

Fatigue in primary biliary cirrhosis.

Abbas G, Jorgensen RA, Lindor KD.

Nat Rev Gastroenterol Hepatol. 2010 Jun;7(6):313-9. doi: 10.1038/nrgastro.2010.62. Epub 2010 May 11. Review.

PMID:
20458334
19.

A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis.

Hegade VS, Bolier R, Oude Elferink RP, Beuers U, Kendrick S, Jones DE.

Frontline Gastroenterol. 2016 Jul;7(3):158-166. doi: 10.1136/flgastro-2015-100618. Epub 2015 Aug 26. Review.

20.

Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?

Sánchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, Herruzo JA.

J Clin Gastroenterol. 1996 Oct;23(3):191-8.

PMID:
8899500

Supplemental Content

Support Center